Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Нервные болезни
2021 / N 1

Механизмы гипоксически-ишемического повреждения мозга при инсульте, пути коррекции
А.В. Романенко, Э.Ю. Соловьева

References

1. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O’Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. The Lancet 2014 Jan;383(9913):245-54.
2. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013 Mar;44(3):870-947.
3. Towfighi A, Saver JL. Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead. Stroke 2011 Aug;42(8):2351-5.
4. Ovbiagele B, Goldstein LB, Higashida RT, Howard VJ, Johnston SC, Khavjou OA, Lackland DT, Lichtman JH, Mohl S, Sacco RL, Saver JL, Trogdon JG; American Heart Association Advocacy Coordinating Committee and Stroke Council. Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke 2013 Aug;44(8):2361-75.
5. Lo EH, Moskowitz MA, Jacobs TP. Exciting, radical, suicidal: how brain cells die after stroke. Stroke 2005 Feb;36(2):189-92.
6. Dalkara T, Arsava EM. Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis? Journal of Cerebral Blood Flow & Metabolism 2012 Dec;32(12):2091-9.
7. Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. Journal of Translational Medicine 2009 Nov;7:97.
8. Maksimovich NE. Nitric oxide and genesis of brain damage in oxidative stress. Proceedings of the National Academy of Sciences of Belarus 2004;2:112-7 (In Russian).
9. Vidale S, Consoli A, Arnaboldi M, Consoli D. Postischemic inflammation in acute stroke. Journal of Clinical Neurology 2017 Jan;13(1):1-9.
10. Solovyeva EYu, Karneyev AN, Chekanov AV, Baranova OA, Tsoi IV. Complex application 2-ethyl-6-methyl-3-oxypyridine-succinate and vinpocetine in cerebrovascular disorder. SS Korsakov Journal of Neurology and Psychiatry 2017;117(5):103-8 (In Russian).
11. Rueda CB, Llorente-Folch I, Traba J, Amigo I, Gonzalez-Sanchez P, Contreras L, Juaristi I, Martinez-Valero P, Pardo B, Del Arco A, Satrustegui J. Glutamate excitotoxicity and Ca2+-regulation of respiration: role of the Ca2+ activated mitochondrial transporters (CaMCs). Biochimica et Biophysics Acta 2016 Aug;1857(8):1158-66.
12. Lai TW, Zhang S, Wang YT. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Progress in Neurobiology 2014 Apr;115:157-88.
13. Mehta SL, Manhas N, Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Research Reviews 2007 Apr;54(1):34-66.
14. Bon EI. Methods of modeling and morphofunctional markers of cerebral ischemia. Journal Biomed 2018;2:59-71 (In Russian).
15. Krzyżanowska W, Pomierny B, Bystrowska B, Pomierny-Chamioło L, Filip M, Budziszewska B, Pera J. Ceftriaxone- and N-acetylcysteine-induced brain tolerance to ischemia: Influence on glutamate levels in focal cerebral ischemia. PLoS One 2017 Oct;12(10):e0186243.
16. Maksimovich NE. Concept of nitroxydergic system of the brain: role of neuronal sources. Journal of Grodno State Medical University 2003;4(4):7-11 (In Russian).
17. Maksimovich NE. Concept of nitroxydergic system of the brain: role of extraneuronal sources. Journal of Grodno State Medical University 2004;1(5):3-5 (In Russian).
18. Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflügers Archiv. European Journal of Physiology 2010 Jul;460(2):525-42.
19. Bon EI, Maksimovich NE. Excitotoxicity in pathogenesis of brain damage in ischemia. Vestnik of Smolensk State Medical Academy 2019;18(1):67-72 (In Russian).
20. Chamorro Á, Dirnagl U, Urra X, Planas AM. Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. The Lancet. Neurology 2016 Jul;15(8):869-81.
21. Chukanova AS, Chukanova EI, Nadareyshvili GG, Guliyeva MSh, Gusev EI. Pathogenetic aspects of development of acute focal cerebral ischemia. SS Korsakov Journal of Neurology and Psychiatry 2017;117(12-2):4-10 (In Russian).
22. Dringen R. Metabolism and functions of glutathione in brain. Progress in Neurobiology 2000 Dec;62(6):649-71.
23. Vinichuk SM. Oxidative stress in acute ischemic stroke and its correction with antioxidant mexidol. International Neurological Journal 2006;4:45-52 (In Russian).
24. Sun MS, Jin H, Sun X, Huang S, Zhang FL, Guo ZN, Yang Y. Free radical damage in ischemia-reperfusion injury: an obstacle in acute ischemic stroke after revascularization therapy. Oxidative Medicine and Cellular Longevity 2018 Jan;2018:3804979.
25. Soodayeva SK. Free-radical mechanisms of injury in respiratory disease. Pulmonologiya 2012;1:5-10 (In Russian).
26. Free radicals, nitricoxide, and inflammation: molecular, biochemical, and clinical aspects. Thomasi A, Özden T, Sculachev VP, editors. NATO Science series: Life and Behavioural Sciences, 344. Amsterdam, Netherlands: IOS Press; 2003: 71-88.
27. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 1991 Jun;43(2):109-42.
28. Margaill I, Allix M, Boulu RG, Plotkine M. Dose- and time-dependence of L-NAME neuroprotection in transient focal cerebral ischaemia in rats. British Journal of Pharmacology 1997 Jan;120(1):160-3.
29. Kiss JP, Vizi ES. Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends in Neurosciences 2001 Apr;24(4):211-5.
30. Conti A, Miscusi M, Cardali S, Germanò A, Suzuki H, Cuzzocrea S, Tomasello F. Nitric oxide in the injured spinal cord: synthases cross-talk, oxidative stress and inflammation. Brain Research Reviews 2007 Apr;54(1):205-18.
31. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nature Reviews. Drug Discovery 2008 Feb;7(2):156-67.
32. Förstermann U. Nitric oxide and oxidative stress in vascular disease. Pflügers Archiv. European Journal of Physiology 2010 May;459(6):923-39.
33. Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, Moskowitz MA. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. Journal of Cerebral Blood Flow & Metabolism 1996 Sep;16(5):981-7.
34. Wei G, Dawson VL, Zweier JL. Role of neuronal and endothelial nitric oxide synthase in nitric oxide generation in the brain following cerebral ischemia. Biochimica et Biophysica Acta 1999 Sep;1455(1):23-34.
35. Samdani AF, Dawson TM, Dawson VL. Nitric oxide synthase in models of focal ischemia. Stroke 1997 Jun;28(6):1283-8.
36. Gürsoy-Ozdemir Y, Bolay H, Saribaş O, Dalkara T. Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia. Stroke 2000;31(8):1974-80; discussion 1981.
37. Trimmer BA, Aprille JR, Dudzinski DM, Lagace CJ, Lewis SM, Michel T, Qazi S, Zayas RM. Nitric oxide and the control of firefly flashing. Science (New York, N.Y.) 2001 Jun;292(5526):2486-8.
38. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiological Reviews 2007 Jan;87(1):315-424.
39. Schopfer FJ, Baker PR, Freeman BA. NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response? Trends in Biochemical Sciences 2003 Dec;28(12):646-54.
40. Kuhn DM, Sakowski SA, Sadidi M, Geddes TJ. Nitrotyrosine as a marker for peroxynitrite-induced neurotoxicity: the beginning or the end of the end of dopamine neurons? Journal of Neurochemistry 2004 May;89(3):529-36.
41. Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, Iadecola C. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proceedings of the National Academy of Sciences of the USA 1998 Sep;95(18):10966-71.
42. Sies H. Oxidative stress: oxidants and antioxidants. Experimental Physiology 1997 Mar;82(2):291-5.
43. Cherubini A, Polidori MC, Bregnocchi M, Pezzuto S, Cecchetti R, Ingegni T, di Iorio A, Senin U, Mecocci P. Antioxidant profile and early outcome in stroke patients. Stroke 2000 Oct;31(10):2295-300.
44. Polidori MC, Cherubini A, Stahl W, Senin U, Sies H, Mecocci P. Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome. Free Radical Research 2002 Mar;36(3):265-8.
45. Gariballa SE, Hutchin TP, Sinclair AJ. Antioxidant capacity after acute ischaemic stroke. QJM 2002 Oct;95(10):685-90.
46. Zhao H, Han Z, Ji X, Luo Y. Epigenetic regulation of oxidative stress in ischemic stroke. Aging and Disease 2016 May;7(3):295-306.
47. Leinonen JS, Ahonen JP, Lönnrot K, Jehkonen P, Molnár G, Alho H. Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke 2000 Jan;31(1):33-9.
48. Yoshioka M, Tanaka Ki, Miyazaki I, Fujita N, Higashi Y, Asanuma M, Ogawa N. The dopamine agonist cabergoline provides neuroprotection by activation of the glutathione system and scavenging free radicals. Neuroscience Research 2002 Jul;43(3):259-67.
49. Robinson NJ, Winge DR. Copper metallochaperones. Annual Review of Biochemistry 2010;79(1):537-62.
50. Lau D, Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacology & Therapeutics 2006 Jul;111(1):16-26.
51. Dröse S, Brandt U. Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Advances in Experimental Medicine and Biology 2012;748:145-69.
52. Kalogeris T, Bao Y, Korthuis RJ. Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning. Redox Biology 2014 Jun;2:702-14.
53. Shenoda B. The role of Na+/Ca2+ exchanger subtypes in neuronal ischemic injury. Translational Stroke Research 2015 Jun;6(3):181-90.
54. Hu F, Liu F. Mitochondrial stress: a bridge between mitochondrial dysfunction and metabolic diseases? Cellular Signaling 2011 Oct;23(10):1528-33.
55. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. Journal of Cerebral Blood Flow and Metabolism 2001 Jan;21(1):2-14.
56. Vijayan M, Reddy PH. Stroke, vascular dementia, and Alzheimer’s disease: molecular links. Journal of Alzheimers Disease 2016 Sep;54(2):427-43.
57. Kim GW, Kondo T, Noshita N, Chan PH. Manganese superoxide dismutase deficiency exacerbates cerebral infarction after focal cerebral ischemia/reperfusion in mice: implications for the production and role of superoxide radicals. Stroke 2002 Mar;33(3):809-15.
58. Murakami K, Kondo T, Kawase M, Li Y, Sato S, Chen SF, Chan PH. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. The Journal of Neuroscience 1998 Jan;18(1):205-13.
59. Vignais PV. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cellular and Molecular Life Sciences 2002 Sep;59(9):1428-59.
60. Walder CE, Green SP, Darbonne WC, Mathias J, Rae J, Dinauer MC, Curnutte JT, Thomas GR. Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke 1997 Nov;28(11):2252-8.
61. Nelson CW, Wei EP, Povlishock JT, Kontos HA, Moskowitz MA. Oxygen radicals in cerebral ischemia. The American Journal of Physiology 1992 Nov;263(5 Pt 2):H1356-62.
62. Lee SJ, Cho KS, Koh JY. Oxidative injury triggers autophagy in astrocytes: the role of endogenous zinc. Glia 2009 Sep;57(12):1351-61.
63. Lee SJ, Koh JY. Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes. Molecular Brain 2010 Oct;3(1):30.
64. Granzotto A, Sensi SL. Intracellular zinc is a critical intermediate in the excitotoxic cascade. Neurobiology of Disease 2015 Sep;81:25-37.
65. Mattson MP. Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Experimental Gerontology 2009 Oct;44(10):625-33.
66. Li P, Hu X, Gan Y, Gao Y, Liang W, Chen J. Mechanistic insight into DNA damage and repair in ischemic stroke: exploiting the base excision repair pathway as a model of neuroprotection. Antioxidants & Redox Signaling 2011 May;14:1905-18.
67. Li W, Luo Y, Zhang F, Signore AP, Gobbel GT, Simon RP, Chen J. Ischemic preconditioning in the rat brain enhances the repair of endogenous oxidative DNA damage by activating the base-excision repair pathway. Journal of Cerebral Blood Flow & Metabolism 2006 Feb;26(2):181-98.
68. Liu D, Croteau DL, Souza-Pinto N, Pitta M, Tian J, Wu C, Jiang H, Mustafa K, Keijzers G, Bohr VA, Mattson MP. Evidence that OGG1 glycosylase protects neurons against oxidative DNA damage and cell death under ischemic conditions. Journal of Cerebral Blood Flow & Metabolism 2011 Feb;31(2):680-92.
69. Jalland CM, Scheffler K, Benestad SL, Moldal T, Ersdal C, Gunnes G, Suganthan R, Bjoras M, Tranulis MA. Neil3 induced neurogenesis protects against prion disease during the clinical phase. Scientific Reports 2016 Nov;6:37844.
70. Shimada M, Dumitrache LC, Russell HR, McKinnon PJ. Polynucleotide kinase-phosphatase enables neurogenesis via multiple DNA repair pathways to maintain genome stability. The EMBO Journal 2015 Oct;34(19):2465-80.
71. Liu Y, Zhang L, Liu Y, Sun C, Zhang H, Miao G, Di CX, Zhou X, Zhou R, Wang Z. DNA-PKcs deficiency inhibits glioblastoma cell-derived angiogenesis after ionizing radiation. Journal of Cellular Physiology 2015 May;230(5):1094-103.
72. Liu B, Li LL, Tan XD, Zhang YH, Jiang Y, He GQ, Chen Q, Li CQ. Gadd45b mediates axonal plasticity and subsequent functional recovery after experimental stroke in rats. Molecular Neurobiology 2015 Dec;52(3):1245-56.
73. Stetler RA, Gao Y, Leak RK, Weng Z, Shi Y, Zhang L, Pu H, Zhang F, Hu X, Hassan S, Ferguson C, Homanics GE, Cao G, Bennett MV, Chen J. APE1/Ref-1 facilitates recovery of gray and white matter and neurological function after mild stroke injury. Proceedings of the National Academy of Sciences of the USA 2016 Jun;113(25):E3558-67.
74. Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiology of Disease 2008 Nov;32(2):200-19.
75. Van der Goes A, Wouters D, Van Der Pol SM, Huizinga R, Ronken E, Adamson P, Greenwood J, Dijkstra CD, De Vries HE. Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro. The FASEB Journal 2001 Aug;15(10):1852-4.
76. Lee HS, Namkoong K, Kim DH, Kim KJ, Cheong YH, Kim SS, Lee WB, Kim KY. Hydrogen peroxide-induced alterations of tight junction proteins in bovine brain microvascular endothelial cells. Microvascular Research 2004 Nov;68(3):231-8.
77. Miller AA, Drummond GR, De Silva TM, Mast AE, Hickey H, Williams JP, Broughton BR, Sobey CG. NADPH oxidase activity is higher in cerebral versus systemic arteries of four animal species: role of Nox2. American Journal of Physiology. Heart and Circulatory Physiology 2009 Jan;296(1):H220-5.
78. Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non–electron transport chain sources. Antioxidants & Redox Signaling 2005 Sep-Oct;7(9-10):1140-9.
79. Lehner C, Gehwolf R, Tempfer H, Krizbai I, Hennig B, Bauer HC, Bauer H. Oxidative stress and blood-brain barrier dysfunction under particular consideration of matrix metalloproteinases. Antioxidants & Redox Signaling 2011 Sep;15(5):1305-23.
80. Sumii T, Lo EH. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 2002 Mar;33(3):831-6.
81. Rohn TT, Hinds TR, Vincenzi FF. Inhibition of Ca2+-pump ATPase and the Na+/K+-pump ATPase by iron-generated free radicals: protection by 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7h-pyrrolo[2,3-d]pyrimidine sulfate (U-89843D), a potent, novel, antioxidant/free radical scavenger. Biochemical Pharmacology 1996 Feb;51(4):471-6.
82. Kourie JI. Interaction of reactive oxygen species with ion transport mechanisms. The American Journal of Physiology 1998 Jul;275(1):C1-24.
83. Blinov DS, Balashov VP, Vankova LV, Skachilova SYa, Belova LA, Blinova EV, Markelova IA. Antiarrhythmic activity of a new domestic antihypoxant ethoxidol. Journal of Arrhythmology 2008;53:41-3 (In Russian).
84. Sernov LN, Smirnov LD, Shaposhnikova GI, Guranova NN. Clinical and experimental study of anti-ischemic and hypolipidemic activity of mexicor. Clinical Studies of Medicines in Russia 2004;1:24-8 (In Russian).
85. Dahlin A, Royall J, Hohmann JG, Wang J. Expression profiling of the solute carrier gene family in the mouse brain. The Journal of Pharmacology and Experimental Therapeutic 2009 May;329(2):558-70.
86. Dadasheva MN, Taranenko NYu, Agafonov BV, Chudakov SYu. Pathogenetic therapy with new domestic antioxidant ethoxidol in cerebrovascular disease. Vestnik Semeynoy Meditsiny 2015;1-2:12-6 (In Russian).
87. Instructions for medical use of the drug Ethoxidol. Solution for intravenous and intramuscular injection, 50 mg/ml. Available from: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=4c4393a2-bea2-4e1d-a48b-51078c0db7fa&t= Accessed 2021 Apr 12 (In Russian).
88. Livanov GA, Aleksandrov MV, Vasilyev SA, Batotsyrenova KhV, Batotsyrenova KhV, Lodyagin AN, Lutsyk MA, Nosov AV. Metabolic desynchronization in critical conditions: experimental study. General Reanimatology 2006;2(1):42-6 (In Russian).
89. Ethoxidol – domestic antioxidant of the 2nd generation: study results. Archakov AI, Kukes VG, Dmitriyev DA, editors. Moscow: IACPP; 2014. 90 p. (In Russian).
90. Instructions for medical use of the drug Ethoxidol®. Chewable tablets, 100 mg. Available from: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=bbdf49a4-2590-42d2-a7d1-d3884cdeed3e&t= Accessed 2021 Apr 12 (In Russian).
91. Goroshko OA, Novikov KN, Kukes VG, Voeykov VL, Arkhipov VV, Buravleva EV, Berdnikova NG, Zhestovskaya AS. Correction of oxidative stress in patients with cerebral ischemia. Clinical Medicine (Russian Journal) 2016;94(7):549-53 (In Russian).
92. Arkhipov VV, Kuzmenko AS. Efficacy of etoxidol during personalized physical rehabilitation in patients in early recovery period after stroke. Medicines and Rational Pharmacotherapy 2013;3:23-30 (In Russian).
93. Kukes VG, Parfenova OK, Romanov BK, Prokofyev AB, Parfenova EV, Sidorov NG, Gazdanova AA, Pavlova LI, Zozina VI, Andreyev AD, Aleksandrova TV, Chernova SV, Ramenskaya GV. Ethoxidol action and oxidative stress indices in heart failure and hypertension. Modern Technologies in Medicine 2020;12(2):67-73 (In Russian).
94. Kukes VG, Parfenova OK, Sidorov NG, Olefir YuV, Gazdanova AA. Oxidative stress and inflammation in COVID-19 pathogenesis. Russian Medical Journal 2020;26(4):244-7 (In Russian).
95. Kukes VG. Study results of ethoxidol – domestic antioxidant of the 2nd generation. Moscow: IACPP; 2017. (In Russian).
96. Mayevskiy EI, Grishina EV, Rozenfeld AS, Bogdanova LA, Kondrashova MN. On feasibility of using food additives based on energy exchange substrates. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2001;11(4):22-8 (In Russian).
97. Karpov AV, Gudz PA, Khrutskiy KS. Efficacy of domestic drug etoxidol in phthisiology. Medical Alliance 2017;2:43-6 (In Russian).
98. Zakharov VV, Novikova MS, Vakhnina NV. Prevention of dementia in patients with mild cognitive impairment. SS Korsakov Journal of Neurology and Psychiatry 2020;120(8):167-74 (In Russian).
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]